NMPA Approval

Ticarcillin Disodium and Clavulanate Potassium for Injection

Approval Number

国药准字H20059792

Company新华制药（高密）有限公司

Registration Date

February 20, 2021

Drug Information

Generic Name

注射用替卡西林钠克拉维酸钾

Dosage Form

注射剂 (无菌分装粉针剂)

Strength

3.2g(C15H16N2O6S2 3.0g与C8H9NO5 0.2g)

Drug Type

化学药品

Registration Date

February 20, 2021

Company Information

Applicant Company

Company Name新华制药（高密）有限公司

Manufacturing Company

Company Name新华制药（高密）有限公司

Company Address

高密市密水街道密水大街（西）2998号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用替卡西林钠克拉维酸钾 - NMPA 批准文号 | MedPath